vs
Ascendis Pharma A/S（ASND）与Axos Financial, Inc.（AX）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是Ascendis Pharma A/S的1.5倍（$392.2M vs $267.3M），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 16.1%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
ASND vs AX — 直观对比
营收规模更大
AX
是对方的1.5倍
$267.3M
两年增速更快
ASND
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $392.2M |
| 净利润 | — | $124.7M |
| 毛利率 | 90.5% | — |
| 营业利润率 | — | — |
| 净利率 | — | 31.8% |
| 营收同比 | 42.3% | — |
| 净利润同比 | — | 18.5% |
| 每股收益（稀释后） | — | $2.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDAX
| Q1 26 | — | $392.2M | ||
| Q4 25 | $267.3M | $385.1M | ||
| Q3 25 | $230.7M | $323.4M | ||
| Q2 25 | $170.7M | $321.4M | ||
| Q1 25 | $109.0M | $308.8M | ||
| Q4 24 | $187.8M | $307.9M | ||
| Q3 24 | $62.5M | $320.7M | ||
| Q2 24 | $38.9M | $290.9M |
净利润ASNDAX
| Q1 26 | — | $124.7M | ||
| Q4 25 | — | $128.4M | ||
| Q3 25 | $-65.9M | $112.4M | ||
| Q2 25 | $-42.0M | $110.7M | ||
| Q1 25 | $-102.2M | $105.2M | ||
| Q4 24 | — | $104.7M | ||
| Q3 24 | $-107.1M | $112.3M | ||
| Q2 24 | $-118.1M | $104.9M |
毛利率ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | 90.5% | — | ||
| Q3 25 | 89.5% | — | ||
| Q2 25 | 80.1% | — | ||
| Q1 25 | 82.6% | — | ||
| Q4 24 | 91.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 68.2% | — |
营业利润率ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | 45.6% | ||
| Q3 25 | 5.1% | 46.3% | ||
| Q2 25 | -33.5% | 48.5% | ||
| Q1 25 | -103.2% | 47.9% | ||
| Q4 24 | — | 48.8% | ||
| Q3 24 | -167.3% | 49.6% | ||
| Q2 24 | -370.2% | 49.6% |
净利率ASNDAX
| Q1 26 | — | 31.8% | ||
| Q4 25 | — | 33.3% | ||
| Q3 25 | -28.5% | 34.7% | ||
| Q2 25 | -24.6% | 34.4% | ||
| Q1 25 | -93.7% | 34.1% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | -171.5% | 35.0% | ||
| Q2 24 | -303.9% | 36.0% |
每股收益（稀释后）ASNDAX
| Q1 26 | — | $2.15 | ||
| Q4 25 | — | $2.22 | ||
| Q3 25 | — | $1.94 | ||
| Q2 25 | — | $1.89 | ||
| Q1 25 | — | $1.81 | ||
| Q4 24 | — | $1.80 | ||
| Q3 24 | — | $1.93 | ||
| Q2 24 | — | $1.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $3.1B |
| 总资产 | $1.4B | $29.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | $665.3M | $1.0B | ||
| Q3 25 | $582.2M | $2.6B | ||
| Q2 25 | $533.6M | $1.9B | ||
| Q1 25 | $559.4M | $2.0B | ||
| Q4 24 | $604.3M | $2.4B | ||
| Q3 24 | $675.6M | $2.6B | ||
| Q2 24 | $279.4M | $2.0B |
总债务ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $312.7M | ||
| Q1 25 | — | $377.4M | ||
| Q4 24 | — | $358.7M | ||
| Q3 24 | — | $313.5M | ||
| Q2 24 | — | $325.7M |
股东权益ASNDAX
| Q1 26 | — | $3.1B | ||
| Q4 25 | $-175.8M | $2.9B | ||
| Q3 25 | $-188.0M | $2.8B | ||
| Q2 25 | $-202.6M | $2.7B | ||
| Q1 25 | $-205.0M | $2.6B | ||
| Q4 24 | $-114.2M | $2.5B | ||
| Q3 24 | $-105.1M | $2.4B | ||
| Q2 24 | $-346.8M | $2.3B |
总资产ASNDAX
| Q1 26 | — | $29.2B | ||
| Q4 25 | $1.4B | $28.2B | ||
| Q3 25 | $1.2B | $27.4B | ||
| Q2 25 | $1.2B | $24.8B | ||
| Q1 25 | $1.1B | $24.0B | ||
| Q4 24 | $1.3B | $23.7B | ||
| Q3 24 | $1.2B | $23.6B | ||
| Q2 24 | $819.0M | $22.9B |
负债/权益比ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $104.1M | ||
| Q3 25 | — | $118.4M | ||
| Q2 25 | — | $490.3M | ||
| Q1 25 | $-15.5M | $73.7M | ||
| Q4 24 | $-330.7M | $162.5M | ||
| Q3 24 | — | $70.8M | ||
| Q2 24 | — | $305.5M |
自由现金流ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | $85.4M | ||
| Q3 25 | — | $109.3M | ||
| Q2 25 | — | $436.1M | ||
| Q1 25 | — | $65.1M | ||
| Q4 24 | — | $156.4M | ||
| Q3 24 | — | $53.0M | ||
| Q2 24 | — | $269.5M |
自由现金流率ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | 22.2% | ||
| Q3 25 | — | 33.8% | ||
| Q2 25 | — | 135.7% | ||
| Q1 25 | — | 21.1% | ||
| Q4 24 | — | 50.8% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | — | 92.6% |
资本支出强度ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 12.4% |
现金转化率ASNDAX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 4.43× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 1.55× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | 2.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
